awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37055879-CB6F2BAF-3EAE-4AD9-BAD5-DB9524EAEE18
Q37055879-CB6F2BAF-3EAE-4AD9-BAD5-DB9524EAEE18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37055879-CB6F2BAF-3EAE-4AD9-BAD5-DB9524EAEE18
Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency.
P2860
Q37055879-CB6F2BAF-3EAE-4AD9-BAD5-DB9524EAEE18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37055879-CB6F2BAF-3EAE-4AD9-BAD5-DB9524EAEE18
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
65b8a52d7b78ece6e9c677eaa21be1ea22d0336a
P2860
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.